CBPO
China Biologic Products Holdings, Inc.
CBPO
CBPO
Delisted
CBPO was delisted on the 20th of April, 2021.
65 hedge funds and large institutions have $953M invested in China Biologic Products Holdings, Inc. in 2014 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 27 increasing their positions, 15 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
65
Holders Change
+11
Holders Change %
+20.37%
% of All Funds
1.73%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
17
Increased
27
Reduced
15
Closed
5
Calls
$807K
Puts
$4.05M
Net Calls
-$3.24M
Net Calls Change
-$2.44M
Top Buyers
| 1 |
MICM
Matthews International Capital Management
San Francisco,
California
|
+$10.3M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$6.85M |
| 3 |
PA
Perceptive Advisors
New York
|
+$4.82M |
| 4 |
Morgan Stanley
New York
|
+$3.97M |
| 5 |
Renaissance Technologies
New York
|
+$3.6M |
Top Sellers
| 1 |
Invesco
Atlanta,
Georgia
|
-$1.21M |
| 2 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$653K |
| 3 |
D.E. Shaw & Co
New York
|
-$583K |
| 4 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$552K |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$539K |
